F A Rocha1, A G Aragão, R C Oliveira, M M Pompeu, M R Vale, R A Ribeiro. 1. Faculdade de Medicina, Departamento de Fisiologia e Farmacologia e Departamento de Medicina Clinica, Universidade Federal do Ceará, Fortaleza CE, Brazil. arocha@ufc.br
Abstract
OBJECTIVE AND DESIGN: We studied the contribution of periarthritis and synovitis to gait disturbance in zymosan (Zy)-induced arthritis. METHODS: Sixty Wistar rats were subjected to injection of Zy (1 mg) into their right knee joints. A first group of animals (GI) had Zy injected through the intact skin. A second group (GII) had Zy injected directly into the articular cavity after excision of the skin and subcutaneous tissue surrounding the joint. Gait disturbance was evaluated using the rat-knee joint incapacitation test. Increase in vascular permeability and cell influx were assessed in joint fluids and joint histology was performed. RESULTS: Zy injection induced a dose-dependent gait disturbance which was maximal at the third/fourth hour of arthritis, being significantly greater in GI rats, whereas cell influx (neutrophils > or = 80%) was maximal at the sixth hour. Cell influx and increase in vasopermeability did not differ between both groups. Histology revealed no significant difference between GI and GII. A third group (GIII), subjected to immune-complex arthritis, that received anti-bovine serum albumin (BSA) antibodies intra-articularly and BSA i.v., did not present gait disturbance, despite the increase in cell counts. CONCLUSIONS: Vascular permeability increase and cell influx are phenomena independent of gait disturbance. Neutrophils do not seem to contribute to development of gait disturbance in Zy arthritis. Sensitization of specific pain receptors in periarticular rather than in synovial tissue is responsible for gait disturbance in Zy-induced arthritis.
OBJECTIVE AND DESIGN: We studied the contribution of periarthritis and synovitis to gait disturbance in zymosan (Zy)-induced arthritis. METHODS: Sixty Wistar rats were subjected to injection of Zy (1 mg) into their right knee joints. A first group of animals (GI) had Zy injected through the intact skin. A second group (GII) had Zy injected directly into the articular cavity after excision of the skin and subcutaneous tissue surrounding the joint. Gait disturbance was evaluated using the rat-knee joint incapacitation test. Increase in vascular permeability and cell influx were assessed in joint fluids and joint histology was performed. RESULTS: Zy injection induced a dose-dependent gait disturbance which was maximal at the third/fourth hour of arthritis, being significantly greater in GI rats, whereas cell influx (neutrophils > or = 80%) was maximal at the sixth hour. Cell influx and increase in vasopermeability did not differ between both groups. Histology revealed no significant difference between GI and GII. A third group (GIII), subjected to immune-complex arthritis, that received anti-bovineserum albumin (BSA) antibodies intra-articularly and BSA i.v., did not present gait disturbance, despite the increase in cell counts. CONCLUSIONS: Vascular permeability increase and cell influx are phenomena independent of gait disturbance. Neutrophils do not seem to contribute to development of gait disturbance in Zy arthritis. Sensitization of specific pain receptors in periarticular rather than in synovial tissue is responsible for gait disturbance in Zy-induced arthritis.
Authors: Mirna M Bezerra; Susan D Brain; Virgínia C C Girão; Stan Greenacre; Julie Keeble; Francisco A C Rocha Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2006-12-15 Impact factor: 3.000
Authors: F A C Rocha; F S Silva; A C R M Leite; A K R M Leite; V C C Girão; R R Castro; F Q Cunha Journal: Br J Pharmacol Date: 2011-09 Impact factor: 8.739
Authors: Ana Carolina Matias Dinelly Pinto; Rossana de Aguiar Cordeiro; José Julio Costa Sidrim; Ana Karine Rocha de Melo Leite; Ana Caroline Rocha de Melo Leite; Virgínia Cláudia Carneiro Girão; Raimunda Sâmia Nogueira Brilhante; Marcos Fábio Gadelha Rocha; Fernando de Queiroz Cunha; Francisco Airton Castro Rocha Journal: Mycopathologia Date: 2013-02-05 Impact factor: 2.574
Authors: Mirna Marques Bezerra; Susan D Brain; Stan Greenacre; Selma Maria Bezerra Jerônimo; Liana Batista de Melo; Julie Keeble; Francisco Airton Castro da Rocha Journal: Br J Pharmacol Date: 2003-12-08 Impact factor: 8.739
Authors: C M Fernandes; C de Fátima Pereira Teixeira; A C R M Leite; J M Gutiérrez; F A C Rocha Journal: Br J Pharmacol Date: 2007-06-25 Impact factor: 8.739
Authors: José C da S Rocha; Magno E B Peixoto; Sônia Jancar; Fernando de Q Cunha; Ronaldo de A Ribeiro; Francisco A C da Rocha Journal: Br J Pharmacol Date: 2002-06 Impact factor: 8.739